BioPorto - Share Issue/Capital Change 2020

Share capital and votes

April 30, 2020

Announcement no. 12

*Share capital and votes*

Pursuant to section 32 of the Danish Capital Markets Act, BioPorto’s nominal share capital totals DKK 199,936,428 consisting of 199,936,428 shares of DKK 1.00, equivalent to 199,936,428 votes. BioPorto’s Articles of Association have been updated accordingly and are available on www.bioporto.com.

For further information, please contact:

Ole Larsen, CFO

Telephone +45 4529 0000, e-mail: [email protected]

About BioPorto

BioPorto is an in vitro diagnostics company that provides tests and antibodies to clinicians and researchers around the world. We use our antibody and assay expertise to transform novel research tools into clinically actionable biomarkers that can make a difference in patients’ lives. BioPorto is headquartered in Hellerup, Denmark and is listed on the NASDAQ Copenhagen stock exchange [CPH:BIOPOR].

Attachment